APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Medical Patch

Compare research editions
View pricing & licenses

Selected research

Industry Research

Transdermal Medical Patch Industry Research Report 2026

2 January 2026136 pages

Choose your research edition.

Industry ResearchTransdermal Medical Patch Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Medical Patch Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Transdermal Medical Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Medical Patch Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Medical Patch Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Transdermal Medical Patch market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Transdermal Medical Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Transdermal Medical Patch is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Transdermal Medical Patch is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Transdermal Medical Patch include Teva Pharmaceutical, Johnson & Johnson, Novartis, Mylan, Pfizer, GSK, Beijing Tide Pharmaceutical, Bayer and UCB Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Transdermal Medical Patch market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Transdermal Medical Patch Market by Company

Teva Pharmaceutical

Johnson & Johnson

Novartis

Mylan

Pfizer

GSK

Beijing Tide Pharmaceutical

Bayer

UCB Pharma

Nitto Denko

Mundipharma

Luye Pharma Group

IBSA Group

Hisamitsu Pharmaceutical

Grünenthal

Endo International

Dr Reddy’s Laboratories

Chattem

Transdermal Medical Patch Segment by Type

Fentanyl Patch

Lidocaine Patch

Rivastigmine Patch

Nicotine Patch

Diclofenac Patch

Methyl Salicylate-Based Patch

Others

Transdermal Medical Patch Segment by Application

Offline Channel

Online Channel

Transdermal Medical Patch Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Medical Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Medical Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Medical Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Transdermal Medical Patch manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Transdermal Medical Patch by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Transdermal Medical Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Transdermal Medical Patch Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Transdermal Medical Patch Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Transdermal Medical Patch Sales Market Share by Manufacturers (2021-2026) Table 8. Global Transdermal Medical Patch Revenue of Manufacturers (2021-2026) Table 9. Global Transdermal Medical Patch Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Transdermal Medical Patch Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Transdermal Medical Patch Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Transdermal Medical Patch, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Transdermal Medical Patch, Product Type & Application Table 14. Global Transdermal Medical Patch Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Transdermal Medical Patch by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Pharmaceutical Company Information Table 19. Teva Pharmaceutical Business Overview Table 20. Teva Pharmaceutical Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Teva Pharmaceutical Transdermal Medical Patch Product Portfolio Table 22. Teva Pharmaceutical Recent Developments Table 23. Johnson & Johnson Company Information Table 24. Johnson & Johnson Business Overview Table 25. Johnson & Johnson Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Johnson & Johnson Transdermal Medical Patch Product Portfolio Table 27. Johnson & Johnson Recent Developments Table 28. Novartis Company Information Table 29. Novartis Business Overview Table 30. Novartis Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Novartis Transdermal Medical Patch Product Portfolio Table 32. Novartis Recent Developments Table 33. Mylan Company Information Table 34. Mylan Business Overview Table 35. Mylan Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Mylan Transdermal Medical Patch Product Portfolio Table 37. Mylan Recent Developments Table 38. Pfizer Company Information Table 39. Pfizer Business Overview Table 40. Pfizer Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Pfizer Transdermal Medical Patch Product Portfolio Table 42. Pfizer Recent Developments Table 43. GSK Company Information Table 44. GSK Business Overview Table 45. GSK Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. GSK Transdermal Medical Patch Product Portfolio Table 47. GSK Recent Developments Table 48. Beijing Tide Pharmaceutical Company Information Table 49. Beijing Tide Pharmaceutical Business Overview Table 50. Beijing Tide Pharmaceutical Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Beijing Tide Pharmaceutical Transdermal Medical Patch Product Portfolio Table 52. Beijing Tide Pharmaceutical Recent Developments Table 53. Bayer Company Information Table 54. Bayer Business Overview Table 55. Bayer Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Bayer Transdermal Medical Patch Product Portfolio Table 57. Bayer Recent Developments Table 58. UCB Pharma Company Information Table 59. UCB Pharma Business Overview Table 60. UCB Pharma Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. UCB Pharma Transdermal Medical Patch Product Portfolio Table 62. UCB Pharma Recent Developments Table 63. Nitto Denko Company Information Table 64. Nitto Denko Business Overview Table 65. Nitto Denko Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Nitto Denko Transdermal Medical Patch Product Portfolio Table 67. Nitto Denko Recent Developments Table 68. Mundipharma Company Information Table 69. Mundipharma Business Overview Table 70. Mundipharma Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Mundipharma Transdermal Medical Patch Product Portfolio Table 72. Mundipharma Recent Developments Table 73. Luye Pharma Group Company Information Table 74. Luye Pharma Group Business Overview Table 75. Luye Pharma Group Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Luye Pharma Group Transdermal Medical Patch Product Portfolio Table 77. Luye Pharma Group Recent Developments Table 78. IBSA Group Company Information Table 79. IBSA Group Business Overview Table 80. IBSA Group Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. IBSA Group Transdermal Medical Patch Product Portfolio Table 82. IBSA Group Recent Developments Table 83. Hisamitsu Pharmaceutical Company Information Table 84. Hisamitsu Pharmaceutical Business Overview Table 85. Hisamitsu Pharmaceutical Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Hisamitsu Pharmaceutical Transdermal Medical Patch Product Portfolio Table 87. Hisamitsu Pharmaceutical Recent Developments Table 88. Grünenthal Company Information Table 89. Grünenthal Business Overview Table 90. Grünenthal Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Grünenthal Transdermal Medical Patch Product Portfolio Table 92. Grünenthal Recent Developments Table 93. Endo International Company Information Table 94. Endo International Business Overview Table 95. Endo International Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Endo International Transdermal Medical Patch Product Portfolio Table 97. Endo International Recent Developments Table 98. Dr Reddy’s Laboratories Company Information Table 99. Dr Reddy’s Laboratories Business Overview Table 100. Dr Reddy’s Laboratories Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Dr Reddy’s Laboratories Transdermal Medical Patch Product Portfolio Table 102. Dr Reddy’s Laboratories Recent Developments Table 103. Chattem Company Information Table 104. Chattem Business Overview Table 105. Chattem Transdermal Medical Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Chattem Transdermal Medical Patch Product Portfolio Table 107. Chattem Recent Developments Table 108. Global Transdermal Medical Patch Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Transdermal Medical Patch Sales by Region (2021-2026) & (K Units) Table 110. Global Transdermal Medical Patch Sales Market Share by Region (2021-2026) Table 111. Global Transdermal Medical Patch Sales by Region (2027-2032) & (K Units) Table 112. Global Transdermal Medical Patch Sales Market Share by Region (2027-2032) Table 113. Global Transdermal Medical Patch Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Transdermal Medical Patch Revenue Market Share by Region (2021-2026) Table 115. Global Transdermal Medical Patch Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Transdermal Medical Patch Revenue Market Share by Region (2027-2032) Table 117. North America Transdermal Medical Patch Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Transdermal Medical Patch Sales by Country (2021-2026) & (K Units) Table 119. North America Transdermal Medical Patch Sales by Country (2027-2032) & (K Units) Table 120. North America Transdermal Medical Patch Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Transdermal Medical Patch Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Transdermal Medical Patch Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Transdermal Medical Patch Sales by Country (2021-2026) & (K Units) Table 124. Europe Transdermal Medical Patch Sales by Country (2027-2032) & (K Units) Table 125. Europe Transdermal Medical Patch Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Transdermal Medical Patch Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Transdermal Medical Patch Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Transdermal Medical Patch Sales by Country (2021-2026) & (K Units) Table 129. Asia Pacific Transdermal Medical Patch Sales by Country (2027-2032) & (K Units) Table 130. Asia Pacific Transdermal Medical Patch Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Transdermal Medical Patch Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Transdermal Medical Patch Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Transdermal Medical Patch Sales by Country (2021-2026) & (K Units) Table 134. South America Transdermal Medical Patch Sales by Country (2027-2032) & (K Units) Table 135. South America Transdermal Medical Patch Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Transdermal Medical Patch Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Transdermal Medical Patch Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Transdermal Medical Patch Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Transdermal Medical Patch Sales by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Transdermal Medical Patch Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Transdermal Medical Patch Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Transdermal Medical Patch Sales by Type (2021-2026) & (K Units) Table 143. Global Transdermal Medical Patch Sales by Type (2027-2032) & (K Units) Table 144. Global Transdermal Medical Patch Sales Market Share by Type (2021-2026) Table 145. Global Transdermal Medical Patch Sales Market Share by Type (2027-2032) Table 146. Global Transdermal Medical Patch Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Transdermal Medical Patch Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Transdermal Medical Patch Revenue Market Share by Type (2021-2026) Table 149. Global Transdermal Medical Patch Revenue Market Share by Type (2027-2032) Table 150. Global Transdermal Medical Patch Price by Type (2021-2026) & (US$/Unit) Table 151. Global Transdermal Medical Patch Price by Type (2027-2032) & (US$/Unit) Table 152. Global Transdermal Medical Patch Sales by Application (2021-2026) & (K Units) Table 153. Global Transdermal Medical Patch Sales by Application (2027-2032) & (K Units) Table 154. Global Transdermal Medical Patch Sales Market Share by Application (2021-2026) Table 155. Global Transdermal Medical Patch Sales Market Share by Application (2027-2032) Table 156. Global Transdermal Medical Patch Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Transdermal Medical Patch Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Transdermal Medical Patch Revenue Market Share by Application (2021-2026) Table 159. Global Transdermal Medical Patch Revenue Market Share by Application (2027-2032) Table 160. Global Transdermal Medical Patch Price by Application (2021-2026) & (US$/Unit) Table 161. Global Transdermal Medical Patch Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Transdermal Medical Patch Distributors List Table 165. Transdermal Medical Patch Customers List Table 166. Transdermal Medical Patch Industry Trends Table 167. Transdermal Medical Patch Industry Drivers Table 168. Transdermal Medical Patch Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Transdermal Medical Patch Product Image Figure 5. Global Transdermal Medical Patch Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Transdermal Medical Patch Market Size (2021-2032) & (US$ Million) Figure 7. Global Transdermal Medical Patch Sales (2021-2032) & (K Units) Figure 8. Global Transdermal Medical Patch Average Price (US$/Unit) & (2021-2032) Figure 9. Fentanyl Patch Product Image Figure 10. Lidocaine Patch Product Image Figure 11. Rivastigmine Patch Product Image Figure 12. Nicotine Patch Product Image Figure 13. Diclofenac Patch Product Image Figure 14. Methyl Salicylate-Based Patch Product Image Figure 15. Others Product Image Figure 16. Offline Channel Product Image Figure 17. Online Channel Product Image Figure 18. Global Transdermal Medical Patch Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of Transdermal Medical Patch, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 Transdermal Medical Patch Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Transdermal Medical Patch Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global Transdermal Medical Patch Sales by Region in 2025 Figure 24. Global Transdermal Medical Patch Revenue by Region in 2025 Figure 25. North America Transdermal Medical Patch Market Size by Country in 2025 Figure 26. North America Transdermal Medical Patch Sales Market Share by Country (2021-2032) Figure 27. North America Transdermal Medical Patch Revenue Market Share by Country (2021-2032) Figure 28. United States Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Transdermal Medical Patch Market Size by Country in 2025 Figure 31. Europe Transdermal Medical Patch Sales Market Share by Country (2021-2032) Figure 32. Europe Transdermal Medical Patch Revenue Market Share by Country (2021-2032) Figure 33. Germany Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Nordic Countries Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Transdermal Medical Patch Market Size by Country in 2025 Figure 40. Asia Pacific Transdermal Medical Patch Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Transdermal Medical Patch Revenue Market Share by Country (2021-2032) Figure 42. China Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. China Taiwan Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Transdermal Medical Patch Market Size by Country in 2025 Figure 51. South America Transdermal Medical Patch Sales Market Share by Country (2021-2032) Figure 52. South America Transdermal Medical Patch Revenue Market Share by Country (2021-2032) Figure 53. Mexico Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Brazil Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Transdermal Medical Patch Market Size by Country in 2025 Figure 57. Middle East and Africa Transdermal Medical Patch Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Transdermal Medical Patch Revenue Market Share by Country (2021-2032) Figure 59. Turkey Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. UAE Transdermal Medical Patch Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Global Transdermal Medical Patch Sales Market Share by Type (2021-2032) Figure 63. Global Transdermal Medical Patch Revenue Market Share by Type (2021-2032) Figure 64. Global Transdermal Medical Patch Price (US$/Unit) by Type (2021-2032) Figure 65. Global Transdermal Medical Patch Sales Market Share by Application (2021-2032) Figure 66. Global Transdermal Medical Patch Revenue Market Share by Application (2021-2032) Figure 67. Global Transdermal Medical Patch Price (US$/Unit) by Application (2021-2032) Figure 68. Transdermal Medical Patch Value Chain Figure 69. Transdermal Medical Patch Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Transdermal Medical Patch Industry Opportunities and Challenges

Scope & coverage.

Types
  • Fentanyl Patch
  • Lidocaine Patch
  • Rivastigmine Patch
  • Nicotine Patch
  • Diclofenac Patch
  • Methyl Salicylate-Based Patch
  • Others
Applications
  • Offline Channel
  • Online Channel
Companies covered
  • Teva Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Pfizer
  • GSK
  • Beijing Tide Pharmaceutical
  • Bayer
  • UCB Pharma
  • Nitto Denko
  • Mundipharma
  • Luye Pharma Group
  • IBSA Group
  • Hisamitsu Pharmaceutical
  • Grünenthal
  • Endo International
  • Dr Reddy’s Laboratories
  • Chattem

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Transdermal Medical Patch Market Size (2021-2032)
  4. 2.2.2 Global Transdermal Medical Patch Sales (2021-2032)
  5. 2.2.3 Global Transdermal Medical Patch Market Average Price (2021-2032)
  6. 2.3 Transdermal Medical Patch by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Fentanyl Patch
  9. 2.3.3 Lidocaine Patch
  10. 2.3.4 Rivastigmine Patch
  11. 2.3.5 Nicotine Patch
  12. 2.3.6 Diclofenac Patch
  13. 2.3.7 Methyl Salicylate-Based Patch
  14. 2.3.8 Others
  15. 2.4 Transdermal Medical Patch by Application
  16. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  17. 2.4.2 Offline Channel
  18. 2.4.3 Online Channel
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Transdermal Medical Patch Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Transdermal Medical Patch Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Transdermal Medical Patch Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Transdermal Medical Patch Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Transdermal Medical Patch Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Transdermal Medical Patch, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Transdermal Medical Patch, Product Type & Application
  8. 3.8 Global Manufacturers of Transdermal Medical Patch, Established Date
  9. 3.9 Global Transdermal Medical Patch Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva Pharmaceutical
  2. 4.1.1 Teva Pharmaceutical Company Information
  3. 4.1.2 Teva Pharmaceutical Business Overview
  4. 4.1.3 Teva Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Pharmaceutical Transdermal Medical Patch Product Portfolio
  6. 4.1.5 Teva Pharmaceutical Recent Developments
  7. 4.2 Johnson & Johnson
  8. 4.2.1 Johnson & Johnson Company Information
  9. 4.2.2 Johnson & Johnson Business Overview
  10. 4.2.3 Johnson & Johnson Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Johnson & Johnson Transdermal Medical Patch Product Portfolio
  12. 4.2.5 Johnson & Johnson Recent Developments
  13. 4.3 Novartis
  14. 4.3.1 Novartis Company Information
  15. 4.3.2 Novartis Business Overview
  16. 4.3.3 Novartis Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Novartis Transdermal Medical Patch Product Portfolio
  18. 4.3.5 Novartis Recent Developments
  19. 4.4 Mylan
  20. 4.4.1 Mylan Company Information
  21. 4.4.2 Mylan Business Overview
  22. 4.4.3 Mylan Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Mylan Transdermal Medical Patch Product Portfolio
  24. 4.4.5 Mylan Recent Developments
  25. 4.5 Pfizer
  26. 4.5.1 Pfizer Company Information
  27. 4.5.2 Pfizer Business Overview
  28. 4.5.3 Pfizer Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Pfizer Transdermal Medical Patch Product Portfolio
  30. 4.5.5 Pfizer Recent Developments
  31. 4.6 GSK
  32. 4.6.1 GSK Company Information
  33. 4.6.2 GSK Business Overview
  34. 4.6.3 GSK Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 GSK Transdermal Medical Patch Product Portfolio
  36. 4.6.5 GSK Recent Developments
  37. 4.7 Beijing Tide Pharmaceutical
  38. 4.7.1 Beijing Tide Pharmaceutical Company Information
  39. 4.7.2 Beijing Tide Pharmaceutical Business Overview
  40. 4.7.3 Beijing Tide Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Beijing Tide Pharmaceutical Transdermal Medical Patch Product Portfolio
  42. 4.7.5 Beijing Tide Pharmaceutical Recent Developments
  43. 4.8 Bayer
  44. 4.8.1 Bayer Company Information
  45. 4.8.2 Bayer Business Overview
  46. 4.8.3 Bayer Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Bayer Transdermal Medical Patch Product Portfolio
  48. 4.8.5 Bayer Recent Developments
  49. 4.9 UCB Pharma
  50. 4.9.1 UCB Pharma Company Information
  51. 4.9.2 UCB Pharma Business Overview
  52. 4.9.3 UCB Pharma Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 UCB Pharma Transdermal Medical Patch Product Portfolio
  54. 4.9.5 UCB Pharma Recent Developments
  55. 4.10 Nitto Denko
  56. 4.10.1 Nitto Denko Company Information
  57. 4.10.2 Nitto Denko Business Overview
  58. 4.10.3 Nitto Denko Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Nitto Denko Transdermal Medical Patch Product Portfolio
  60. 4.10.5 Nitto Denko Recent Developments
  61. 4.11 Mundipharma
  62. 4.11.1 Mundipharma Company Information
  63. 4.11.2 Mundipharma Business Overview
  64. 4.11.3 Mundipharma Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Mundipharma Transdermal Medical Patch Product Portfolio
  66. 4.11.5 Mundipharma Recent Developments
  67. 4.12 Luye Pharma Group
  68. 4.12.1 Luye Pharma Group Company Information
  69. 4.12.2 Luye Pharma Group Business Overview
  70. 4.12.3 Luye Pharma Group Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Luye Pharma Group Transdermal Medical Patch Product Portfolio
  72. 4.12.5 Luye Pharma Group Recent Developments
  73. 4.13 IBSA Group
  74. 4.13.1 IBSA Group Company Information
  75. 4.13.2 IBSA Group Business Overview
  76. 4.13.3 IBSA Group Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 IBSA Group Transdermal Medical Patch Product Portfolio
  78. 4.13.5 IBSA Group Recent Developments
  79. 4.14 Hisamitsu Pharmaceutical
  80. 4.14.1 Hisamitsu Pharmaceutical Company Information
  81. 4.14.2 Hisamitsu Pharmaceutical Business Overview
  82. 4.14.3 Hisamitsu Pharmaceutical Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Hisamitsu Pharmaceutical Transdermal Medical Patch Product Portfolio
  84. 4.14.5 Hisamitsu Pharmaceutical Recent Developments
  85. 4.15 Grünenthal
  86. 4.15.1 Grünenthal Company Information
  87. 4.15.2 Grünenthal Business Overview
  88. 4.15.3 Grünenthal Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Grünenthal Transdermal Medical Patch Product Portfolio
  90. 4.15.5 Grünenthal Recent Developments
  91. 4.16 Endo International
  92. 4.16.1 Endo International Company Information
  93. 4.16.2 Endo International Business Overview
  94. 4.16.3 Endo International Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Endo International Transdermal Medical Patch Product Portfolio
  96. 4.16.5 Endo International Recent Developments
  97. 4.17 Dr Reddy’s Laboratories
  98. 4.17.1 Dr Reddy’s Laboratories Company Information
  99. 4.17.2 Dr Reddy’s Laboratories Business Overview
  100. 4.17.3 Dr Reddy’s Laboratories Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Dr Reddy’s Laboratories Transdermal Medical Patch Product Portfolio
  102. 4.17.5 Dr Reddy’s Laboratories Recent Developments
  103. 4.18 Chattem
  104. 4.18.1 Chattem Company Information
  105. 4.18.2 Chattem Business Overview
  106. 4.18.3 Chattem Transdermal Medical Patch Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Chattem Transdermal Medical Patch Product Portfolio
  108. 4.18.5 Chattem Recent Developments
5 Global Transdermal Medical Patch Market Scenario by Region
  1. 5.1 Global Transdermal Medical Patch Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Transdermal Medical Patch Sales by Region: 2021-2032
  3. 5.2.1 Global Transdermal Medical Patch Sales by Region: 2021-2026
  4. 5.2.2 Global Transdermal Medical Patch Sales by Region: 2027-2032
  5. 5.3 Global Transdermal Medical Patch Revenue by Region: 2021-2032
  6. 5.3.1 Global Transdermal Medical Patch Revenue by Region: 2021-2026
  7. 5.3.2 Global Transdermal Medical Patch Revenue by Region: 2027-2032
  8. 5.4 North America Transdermal Medical Patch Market Facts & Figures by Country
  9. 5.4.1 North America Transdermal Medical Patch Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Transdermal Medical Patch Sales by Country (2021-2032)
  11. 5.4.3 North America Transdermal Medical Patch Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Transdermal Medical Patch Market Facts & Figures by Country
  15. 5.5.1 Europe Transdermal Medical Patch Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Transdermal Medical Patch Sales by Country (2021-2032)
  17. 5.5.3 Europe Transdermal Medical Patch Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Transdermal Medical Patch Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Transdermal Medical Patch Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Transdermal Medical Patch Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Transdermal Medical Patch Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Transdermal Medical Patch Market Facts & Figures by Country
  36. 5.7.1 South America Transdermal Medical Patch Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Transdermal Medical Patch Sales by Country (2021-2032)
  38. 5.7.3 South America Transdermal Medical Patch Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.8 Middle East and Africa Transdermal Medical Patch Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Transdermal Medical Patch Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Transdermal Medical Patch Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Transdermal Medical Patch Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Transdermal Medical Patch Sales by Type (2021-2032)
  2. 6.1.1 Global Transdermal Medical Patch Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Transdermal Medical Patch Sales Market Share by Type (2021-2032)
  4. 6.2 Global Transdermal Medical Patch Revenue by Type (2021-2032)
  5. 6.2.1 Global Transdermal Medical Patch Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Transdermal Medical Patch Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Transdermal Medical Patch Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Transdermal Medical Patch Sales by Application (2021-2032)
  2. 7.1.1 Global Transdermal Medical Patch Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Transdermal Medical Patch Sales Market Share by Application (2021-2032)
  4. 7.2 Global Transdermal Medical Patch Revenue by Application (2021-2032)
  5. 7.2.1 Global Transdermal Medical Patch Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Transdermal Medical Patch Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Transdermal Medical Patch Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Transdermal Medical Patch Value Chain Analysis
  2. 8.1.1 Transdermal Medical Patch Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Transdermal Medical Patch Production Mode & Process
  5. 8.2 Transdermal Medical Patch Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Transdermal Medical Patch Distributors
  8. 8.2.3 Transdermal Medical Patch Customers
9 Global Transdermal Medical Patch Analyzing Market Dynamics
  1. 9.1 Transdermal Medical Patch Industry Trends
  2. 9.2 Transdermal Medical Patch Industry Drivers
  3. 9.3 Transdermal Medical Patch Industry Opportunities and Challenges
  4. 9.4 Transdermal Medical Patch Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst